UAB MIP Pharma Lietuva Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 30,931 |
| 30,931 |
| 20,251 |
| 19,340 |
| 19,340 |
| 99.84 |
| 62.53 |
| 104,641 |
| 1,558 |
| 0 |
| 106,839 |
| 2024 |
|---|
| 38,176 |
| 38,176 |
| 29,607 |
| 28,275 |
| 28,275 |
| 99.92 |
| 74.06 |
| 132,916 |
| 6,326 |
| 0 |
| 139,882 |
| 2025 |
|---|
| 30,055 |
| 30,055 |
| 18,148 |
| 15,809 |
| 15,809 |
| 100.00 |
| 52.60 |
| 148,725 |
| 21,076 |
| 0 |
| 170,441 |
Register and
explore Okredo data| 2025 |
|---|
| 30,055 |
| 30,055 |
| 18,148 |
| 15,809 |
| 15,809 |
| 100.00 |
| 52.60 |
| 148,725 |
| 21,076 |
| 0 |
| 170,441 |
Register and
explore Okredo dataTurnover (€)
2025
Turnover (€)
30,055 €-21 % *
Sales per employee (€)
30,055 €-21 % *
Profit before tax (€)
18,148 €-39 % *
Net Profit (€)
15,809 €-44 % *
Profit per employee (€)
15,809 €-44 % *
Total profitability (%)
100.00 %0.08 % *
Net profitability (%)
52.60 %-28.98 % *
Equity (€)
148,725 €12 % *
Amounts Payable And Liabilities (€)
21,076 €233 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
170,441 €22 % *
